Trinity's life science engineering solutions team includes industry veterans from legacy companies Advent Engineering and Aztec Technologies, which were acquired by Trinity Consultants in 2018 and 2022, respectively. Our team has deep expertise in the commercialization of pharmaceutical/bio-pharmaceutical processes. The team provides a wide array of engineering solutions supporting the entire product life cycle including Process Development, Process Design Engineering, Process Automation, Panel Design & Fabrication, Commissioning, Qualification & Validation, and Project Management. We have expertise in multiple modalities including small molecule, various recombinant DNA technologies, as well as allogeneic & personalized cell and gene therapies. Our engineers are industry leaders and innovators with experience in the application of numerical methods such as computational fluid dynamics to support our clients in compliant production of novel therapies. Throughout the biologics and pharmaceutical product development lifecycle, our team provides a wide variety of services that help bring products to market.